These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31961828)

  • 1. MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.
    Liu H; Osterburg AR; Flury J; Swank Z; McGraw DW; Gupta N; Wikenheiser-Brokamp KA; Kumar A; Tazi A; Inoue Y; Hirose M; McCormack FX; Borchers MT
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31961828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Langerhans Cell Histiocytosis.
    Shaw B; Borchers M; Zander D; Gupta N
    Semin Respir Crit Care Med; 2020 Apr; 41(2):269-279. PubMed ID: 32279297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases.
    Roden AC; Hu X; Kip S; Parrilla Castellar ER; Rumilla KM; Vrana JA; Vassallo R; Ryu JH; Yi ES
    Am J Surg Pathol; 2014 Apr; 38(4):548-51. PubMed ID: 24625419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease.
    Kamionek M; Ahmadi Moghaddam P; Sakhdari A; Kovach AE; Welch M; Meng X; Dresser K; Tomaszewicz K; Cosar EF; Mark EJ; Fraire AE; Hutchinson L
    Histopathology; 2016 Sep; 69(3):499-509. PubMed ID: 26915300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF
    Kambouchner M; Emile JF; Copin MC; Coulomb-Lherminé A; Sabourin JC; Della Valle V; Sileo C; Ducou Le Pointe H; Bégueret H; Galmiche L; Lambilliotte A; Paraf F; Piche M; Piguet C; Rullier A; Secq V; Serre I; Bernaudin JF; Donadieu J
    Hum Pathol; 2019 Jul; 89():51-61. PubMed ID: 31054893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic landscape of adult Langerhans cell histiocytosis with lung involvement.
    Jouenne F; Chevret S; Bugnet E; Clappier E; Lorillon G; Meignin V; Sadoux A; Cohen S; Haziot A; How-Kit A; Kannengiesser C; Lebbé C; Gossot D; Mourah S; Tazi A
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31806714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.
    Berres ML; Lim KP; Peters T; Price J; Takizawa H; Salmon H; Idoyaga J; Ruzo A; Lupo PJ; Hicks MJ; Shih A; Simko SJ; Abhyankar H; Chakraborty R; Leboeuf M; Beltrão M; Lira SA; Heym KM; Bigley V; Collin M; Manz MG; McClain K; Merad M; Allen CE
    J Exp Med; 2014 Apr; 211(4):669-83. PubMed ID: 24638167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis.
    Dimmler A; Geddert H; Werner M; Faller G
    Virchows Arch; 2017 Apr; 470(4):429-435. PubMed ID: 28220299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding and management of pulmonary Langerhans cell histiocytosis.
    Vassallo R; Harari S; Tazi A
    Thorax; 2017 Oct; 72(10):937-945. PubMed ID: 28689173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.
    Roden AC; Yi ES
    Arch Pathol Lab Med; 2016 Mar; 140(3):230-40. PubMed ID: 26927717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I manage pulmonary Langerhans cell histiocytosis.
    Lorillon G; Tazi A
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of BRAF
    Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
    Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Langerhans cell histiocytosis - an update on pathogenesis and treatment.
    Jouenne F; Benattia A; Tazi A
    Curr Opin Pulm Med; 2023 Sep; 29(5):451-458. PubMed ID: 37410483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cell histiocytosis: current advances in molecular pathogenesis.
    Sconocchia T; Foßelteder J; Sconocchia G; Reinisch A
    Front Immunol; 2023; 14():1275085. PubMed ID: 37965340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations.
    Tran G; Huynh TN; Paller AS
    J Am Acad Dermatol; 2018 Mar; 78(3):579-590.e4. PubMed ID: 29107340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between clinicopathologic characteristics and BRAF
    Huang H; Lu T; Sun Y; Li S; Li J; Xu K; Feng RE; Xu ZJ
    Thorac Cancer; 2019 Oct; 10(10):1984-1992. PubMed ID: 31441596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF
    Bigenwald C; Le Berichel J; Wilk CM; Chakraborty R; Chen ST; Tabachnikova A; Mancusi R; Abhyankar H; Casanova-Acebes M; Laface I; Akturk G; Jobson J; Karoulia Z; Martin JC; Grout J; Rafiei A; Lin H; Manz MG; Baccarini A; Poulikakos PI; Brown BD; Gnjatic S; Lujambio A; McClain KL; Picarsic J; Allen CE; Merad M
    Nat Med; 2021 May; 27(5):851-861. PubMed ID: 33958797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis.
    Chilosi M; Facchetti F; Caliò A; Zamò A; Brunelli M; Martignoni G; Rossi A; Montagna L; Piccoli P; Dubini A; Tironi A; Tomassetti S; Poletti V; Doglioni C
    Leuk Lymphoma; 2014 Nov; 55(11):2620-6. PubMed ID: 24471909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan.
    Hayase T; Saito S; Shioda Y; Imamura T; Watanabe K; Ohki K; Yoshioka T; Oh Y; Kawahara Y; Niijima H; Imashuku S; Morimoto A
    Int J Hematol; 2020 Oct; 112(4):560-567. PubMed ID: 32654047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.